scholarly article | Q13442814 |
P356 | DOI | 10.1039/C3NR04268E |
P698 | PubMed publication ID | 24150593 |
P50 | author | Veronica Morea | Q29048223 |
Patrizio Giacomini | Q38642656 | ||
Pierpaolo Ceci | Q43021303 | ||
Carlo Leonetti | Q45362876 | ||
Elisabetta Falvo | Q56285704 | ||
Elisa Tremante | Q56285705 | ||
Rocco Fraioli | Q62686148 | ||
P2093 | author name string | Alberto Boffi | |
Carlotta Zamparelli | |||
P2860 | cites work | Magnetoferritin nanoparticles for targeting and visualizing tumour tissues | Q29400779 |
Protein-based nanocarriers as promising drug and gene delivery systems. | Q30416469 | ||
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. | Q33734849 | ||
CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells. | Q33784789 | ||
Effective encapsulation of a new cationic gadolinium chelate into apoferritin and its evaluation as an MRI contrast agent | Q33824447 | ||
Chimeric ferritin nanocages for multiple function loading and multimodal imaging | Q34565032 | ||
RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors | Q34652361 | ||
Thioaptamer conjugated liposomes for tumor vasculature targeting | Q35640211 | ||
Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma? | Q37029367 | ||
Protein-based nanomedicine platforms for drug delivery | Q37538630 | ||
The ferritin superfamily: Supramolecular templates for materials synthesis | Q37660707 | ||
Superparamagnetic nanoparticles as targeted probes for diagnostic and therapeutic applications | Q37744631 | ||
Reactions inside nanoscale protein cages | Q37860963 | ||
The beating heart of melanomas: a minor subset of cancer cells sustains tumor growth | Q37864489 | ||
CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma | Q37946449 | ||
Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design | Q37949042 | ||
Melanoma molecular classes and prognosis in the postgenomic era. | Q38007231 | ||
The detection and quantitation of protein oligomerization | Q38040717 | ||
Human ferritin for tumor detection and therapy. | Q38100772 | ||
Epidermal growth factor-ferritin H-chain protein nanoparticles for tumor active targeting | Q39343906 | ||
Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform | Q39357148 | ||
Multifunctional ferritin cage nanostructures for fluorescence and MR imaging of tumor cells | Q39443775 | ||
Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin | Q39841874 | ||
Electrostatic assembly of binary nanoparticle superlattices using protein cages | Q57183943 | ||
Magnetic nanoparticles--templated assembly of protein subunits: a new platform for carbohydrate-based MRI nanoprobes | Q57185193 | ||
Magnetic Resonance Visualization of Tumor Angiogenesis by Targeting Neural Cell Adhesion Molecules with the Highly Sensitive Gadolinium-Loaded Apoferritin Probe | Q58831586 | ||
Hierarchical Self-Assembly and Optical Disassembly for Controlled Switching of Magnetoferritin Nanoparticle Magnetism | Q61646482 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nanoparticle | Q61231 |
cisplatin | Q412415 | ||
antibody | Q79460 | ||
P304 | page(s) | 12278-12285 | |
P577 | publication date | 2013-12-01 | |
P1433 | published in | Nanoscale | Q3335756 |
P1476 | title | Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin | |
P478 | volume | 5 |
Q59356102 | Bioengineering Strategies for Protein-Based Nanoparticles |
Q50918966 | CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL. |
Q27704043 | Cisplatin encapsulation within a ferritin nanocage: a high-resolution crystallographic study |
Q48923575 | Conversion of the Native 24-mer Ferritin Nanocage into Its Non-Native 16-mer Analogue by Insertion of Extra Amino Acid Residues |
Q51326343 | Engineering protein interfaces yields ferritin disassembly and reassembly under benign experimental conditions. |
Q38776237 | Ferritin cage for encapsulation and delivery of bioactive nutrients: From structure, property to applications. |
Q88011808 | Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting |
Q87957089 | Functional ferritin nanoparticles for biomedical applications |
Q38664186 | Functionalized protein nanocages as a platform of targeted therapy and immunodetection |
Q34383748 | H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection. |
Q48165104 | Humanized archaeal ferritin as a tool for cell targeted delivery. |
Q26798379 | Nanoparticle-mediated drug delivery for treating melanoma |
Q36978587 | Nanoparticles and nanofibers for topical drug delivery |
Q41007441 | Platinum-conjugated antibodies for application in mass cytometry |
Q45858764 | Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin |
Q116166336 | Role of ARP2/3 Complex-Driven Actin Polymerization in RSV Infection |
Q38254088 | Synthetic and bioinspired cage nanoparticles for drug delivery |
Q36078281 | Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor |
Q39325532 | The regulatory mechanisms of NG2/CSPG4 expression |
Q41183225 | Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model. |
Q36693096 | Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles |
Q60921652 | Very low intensity ultrasounds as a new strategy to improve selective delivery of nanoparticles-complexes in cancer cells |
Q50905102 | X-ray Structure of the Carboplatin-Loaded Apo-Ferritin Nanocage. |
Search more.